Targeting AP-1 with a pharmacologically safe herbal derivative curcumin appears to induce radiosensitization of cancer stem cells through downregulation of c-Fos, c-Jun and upregulation of Fra-1 to make cancer treatment most effective. This evidence concerns the gene JUN and cancer.